Sp180
NON-INVASIVE ASSESSMENTS OF LIVER FIBROSIS FROM POPULATION SCREENING TO MONITORING FIBROSIS PROGRESSION/REGRESSION TO PREDICTING CLINICAL OUTCOMES
Date
May 6, 2023
Explore related products in the following collection:
Society: AASLD
LIVE STREAM SESSION
LIVE STREAM SESSION
Presenter
Icahn School of Medicine at Mount Sinai
Tracks
Related Products
NON-INVASIVE PREDICTION OF HIGH-RISK ESOPHAGEAL VARICES VIA ELECTROCARDIOGRAM-BASED DEEP LEARNING MODEL
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
COMPARISON IN THE MANAGEMENT OF GASTRIC VARICEAL BLEEDING: ENDOSCOPIC VARICEAL LIGATION VERSUS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) VERSUS BALLOON-OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION (BRTO): A FOUR-YEAR NATIONAL COHORT ANALYSIS
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
RACIAL DISPARITIES IN NAFLD-FIBROSIS RISK FACTORS IN THE UNITED STATES POPULATION
BACKGROUND AND AIMS: Screening tools are needed for early detection of NAFLD-fibrosis. We aimed to identify risk factors for NAFLD-fibrosis in the multiethnic population of the U.S. and thus accelerate development of equitable screening tools…
